Evidence map›Paper›PMID 38854780›Full record

ArticleInfection and drug resistance2024

Emergence of an Extensive Drug Resistant

Kexin Guo, Zanzan Zhao, Yu Yang, Xiawei Jiang, Hao Xu, Fangfang Tao, Ye Xu, Wenhong Liu

Abstract read
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Genomic landscape ofApplied and environmental microbiology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kexin Guo *School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Zanzan Zhao *School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Yu YangSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Xiawei JiangSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Hao XuCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Fangfang TaoSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Ye XuSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Wenhong LiuSchool of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.ORCID 0000-0002-9202-0687

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To explore the plasmid characteristics and transfer mechanisms of an extensive drug resistant (XDR) clinical isolate, Methods: Species confirmation of L2724hy was achieved through 16S rRNA sequencing and Average Nucleotide Identity (ANI) analysis. Antimicrobial susceptibility testing (AST) employed the agar dilution and micro broth dilution methods. Identification of resistance genes was carried out by PCR and whole-genome sequencing (WGS). Essential resistance gene locations were verified by S1 nuclease pulsed-field gel electrophoresis (S1-PFGE) and southern hybridization experiments. Subsequent WGS data analysis delved into drug resistance genes and plasmids. Results: The confirmation of the strain L2724hy as an extensive drug-resistant Citrobacter portucalensis, resistant to almost all antibiotics tested except polymyxin B and tigecycline, was achieved through 16S rRNA sequencing, ANI analysis and AST results. WGS and subsequent analysis revealed L2724hy carrying Conclusion: We discovered the coexistence of

Indexed as

blaKPCblaNDMblaSFOCitrobacter sppIncFIIXDR

Identifiers

PMID38854780
PMCPMC11162216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.